www.fdanews.com/articles/115344-nalmefene-north-american-rights-acquired-by-lundbeck
Nalmefene North-American Rights Acquired by Lundbeck
March 12, 2009
Lundbeck has acquired the North-American and Mexican rights for nalmefene from Somaxon Pharmaceuticals.
TradingMarkets
TradingMarkets